Skip to main content

Quince Therapeutics, Inc.

QNCX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001662774

No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Quince Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
102
−28 vs. Q3 2021
Shares held
19.2M
+151.9K (+0.8%) vs. Q3 2021
Total value
$242.8M
−$1.51B (−86.1%) vs. Q3 2021
New holders
25
38 more added
Sold out
53
24 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 102 institutions
Q1 2021: 91 institutionsQ2 2021: 105 institutionsQ3 2021: 131 institutionsQ4 2021: 102 institutionsQ1 2022: 88 institutionsQ2 2022: 70 institutionsQ3 2022: 61 institutionsQ4 2022: 50 institutionsQ1 2023: 45 institutionsQ2 2023: 40 institutionsQ3 2023: 42 institutionsQ4 2023: 44 institutionsQ1 2024: 46 institutionsQ2 2024: 43 institutionsQ3 2024: 33 institutionsQ4 2024: 35 institutionsQ1 2025: 36 institutionsQ2 2025: 41 institutionsQ3 2025: 45 institutionsQ4 2025: 67 institutionsQ1 2026: 46 institutionsQ2 2026: 26 institutions
Value heldQ4 2021: $242.8M
Q1 2021: $673.5MQ2 2021: $982.9MQ3 2021: $1.76BQ4 2021: $242.8MQ1 2022: $99.5MQ2 2022: $26.0MQ3 2022: $12.4MQ4 2022: $3.44MQ1 2023: $12.0MQ2 2023: $13.5MQ3 2023: $8.40MQ4 2023: $7.83MQ1 2024: $7.71MQ2 2024: $4.68MQ3 2024: $4.04MQ4 2024: $9.55MQ1 2025: $6.96MQ2 2025: $12.5MQ3 2025: $19.2MQ4 2025: $67.5MQ1 2026: $1.44MQ2 2026: $4.74M
Institutions holding QNCX and their total value by quarter
QuarterHoldersValue
Q2 202626$4.74M
Q1 202646$1.44M
Q4 202567$67.5M
Q3 202545$19.2M
Q2 202541$12.5M
Q1 202536$6.96M
Q4 202435$9.55M
Q3 202433$4.04M
Q2 202443$4.68M
Q1 202446$7.71M
Q4 202344$7.83M
Q3 202342$8.40M
Q2 202340$13.5M
Q1 202345$12.0M
Q4 202250$3.44M
Q3 202261$12.4M
Q2 202270$26.0M
Q1 202288$99.5M
Q4 2021102$242.8M
Q3 2021131$1.76B
Q2 2021105$982.9M
Q1 202191$673.5M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding QNCX in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Capital World Investors2,501,882$31.6M0.00%−985,113−28.3%Reduced
EPIQ Capital Group, LLC4,269,109$53.9M9.57%+315,514+8.0%Added
Capital Research Global Investors0$00.00%−2,315,839−100.0%Sold out
Caption Management, LLC0$00.00%−69,800−100.0%Sold out
Marshall Wace, LLP0$00.00%−60,701−100.0%Sold out
Alps Advisors Inc0$00.00%−36,384−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−26,905−100.0%Sold out
Ikarian Capital, LLC0$00.00%−20,160−100.0%Sold out
ICONIQ Capital, LLC0$00.00%−18,420−100.0%Sold out
HRT Financial LP0$00.00%−14,332−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−14,059−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−13,179−100.0%Sold out
Hamilton Lane Advisors LLC0$00.00%−12,612−100.0%Sold out
HAP Trading, LLC0$00.00%−11,881−100.0%Sold out
Principal Financial Group Inc0$00.00%−10,222−100.0%Sold out
DekaBank Deutsche Girozentrale0$00.00%−10,000−100.0%Sold out
SG Americas Securities, LLC0$00.00%−9,730−100.0%Sold out
SG3 Management, LLC0$00.00%−9,000−100.0%Sold out
ProShare Advisors LLC0$00.00%−8,900−100.0%Sold out
Cherry Creek Investment Advisors, Inc.0$00.00%−8,873−100.0%Sold out
Parametric Portfolio Associates LLC0$00.00%−8,268−100.0%Sold out
Voya Investment Management LLC0$00.00%−7,788−100.0%Sold out
Invesco Ltd.0$00.00%−7,552−100.0%Sold out
Bellwether Advisors, LLC0$00.00%−6,934−100.0%Sold out
Cinctive Capital Management LP0$00.00%−6,000−100.0%Sold out
Letko, Brosseau & Associates Inc0$00.00%−5,473−100.0%Sold out
TD Asset Management Inc0$00.00%−5,200−100.0%Sold out
Saturna Capital CORP0$00.00%−5,110−100.0%Sold out
Aj Wealth Strategies, LLC0$00.00%−4,520−100.0%Sold out
Arizona State Retirement System0$00.00%−4,433−100.0%Sold out
Trexquant Investment LP0$00.00%−4,195−100.0%Sold out
17 Capital Partners, LLC0$00.00%−3,675−100.0%Sold out
Gotham Asset Management, LLC0$00.00%−3,659−100.0%Sold out
Amalgamated Bank0$00.00%−3,549−100.0%Sold out
Ameriprise Financial Inc0$00.00%−3,375−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−3,205−100.0%Sold out
Running Point Capital Advisors, LLC0$00.00%−3,182−100.0%Sold out
Independent Financial Group, LLC0$00.00%−3,175−100.0%Sold out
Foster Dykema Cabot & Co Inc0$00.00%−3,061−100.0%Sold out
Atlas Capital Advisors LLC0$00.00%−3,000−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−2,609−100.0%Sold out
Golden State Wealth Management, LLC0$00.00%−2,555−100.0%Sold out
Creative Planning0$00.00%−2,510−100.0%Sold out
55I, LLC0$00.00%−2,400−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−2,360−100.0%Sold out
Cedar Brook Financial Partners, LLC0$00.00%−2,218−100.0%Sold out
Seven Eight Capital, LP0$00.00%−2,200−100.0%Sold out
FMR LLC0$00.00%−1,947−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−1,000−100.0%Sold out
Meeder Asset Management Inc0$00.00%−850−100.0%Sold out
Hershey Trust Co0$00.00%−691−100.0%Sold out
Penserra Capital Management LLC0$00.00%−680−100.0%Sold out
Prentice Wealth Management LLC0$00.00%−65−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−46−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−19−100.0%Sold out
Marshall Wace North America L.P.––––Not filed